Skip to main content

Monitoring of transglutaminase2 under different oxidative stress conditions

Abstract

Transglutaminase 2 (TG2) is a multifunctional calcium-dependent enzyme which catalyzes the post-translational protein crosslinking with formation of intra- or inter-molecular epsilon(gamma-glutamyl)lysine bonds or polyamine incorporation. The up-regulation and activation of TG2 have been reported in a variety of physiological events, including cell differentiation, signal transduction, apoptosis, and wound healing, as well as in cell response to stress evoked by different internal and external stimuli. Here we review TG2 role in cell response to redox state imbalance both under physiological and pathological conditions, such as neurodegenerative disorders, inflammation, autoimmune diseases and cataractogenesis, in which oxidative stress plays a pathogenetic role and also accelerates disease progression. The increase in TG activity together with mitochondrial impairment and collapse of antioxidant enzymatic cell defences have been reported to be the prominent biochemical alterations becoming evident prior to neurodegeneration. Moreover, oxidative stress-induced TG2 pathway is involved in autophagy inhibition and aggresome formation, and TG2 has been suggested to function as a link between oxidative stress and inflammation by driving the decision as to whether a protein should undergo SUMO-mediated regulation or proteasomal degradation. Literature data suggest a strong association between oxidative stress and TG2 up-regulation, which in turn may result in cell survival or apoptosis, depending on cell type, kind of stressor, duration of insult, as well as TG2 intracellular localization and activity state. In particular, it may be suggested that TG2 plays a pro-survival role when the alteration of cell redox state homeostasis is not associated with intracellular calcium increase triggering TG2 transamidation activity.

This is a preview of subscription content, access via your institution.

Fig. 1

Abbreviations

AD:

Alzheimer’s disease

ALS:

Amyotrophic lateral sclerosis

CF:

Cystic fibrosis

CFTR:

Transmembrane conductance regulator gene

chlTGZ:

Chloroplast transglutaminase

Hcy:

Homocysteine

HD:

Huntington’s disease

4-HPR:

N-(4-hydroxyphenyl)retinamide

LPA:

Lysophosphatidic acid

LPS:

Lipopolysaccharide

NF-κB:

Nuclear factor-κB

3-NP:

3-Nitropropionic acid

PBMC:

Peripheral blood mononuclear cells

PD:

Parkinson’s disease

PPAR:

Peroxisome proliferator-activated receptor

ROS:

Reactive oxygen species

SUMO:

Small ubiquitin-like modifier

TG:

Transglutaminase

TG2:

Tissue transglutaminase

TGF-beta:

Transforming growth factor-beta

References

  • Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA (2001) Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 276(36):33582–33587

    Google Scholar 

  • Antonyak MA, McNeill CJ, Wakshlag JJ, Boehm JE, Cerione RA (2003) Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J Biol Chem 278:15859–15866

    PubMed  Article  CAS  Google Scholar 

  • Azzi A (2007) Oxidative stress: a dead end or a laboratory hypothesis? Biochem Biophys Res Commun 362:230–232

    PubMed  Article  CAS  Google Scholar 

  • Battaglia G, Farrace MG, Mastroberardino PG, Viti I, Fimia GM, van Beeumen J, Devreese B, Melino G, Molinaro G, Busceti CL, Biagioni F, Nicoletti F, Piacentini M (2007) Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J Neurochem 100(1):36–49

    PubMed  Article  CAS  Google Scholar 

  • Battelli MG, Musiani S, Tazzari PL, Stirpe F (2001) Oxidative stress to human lymphocytes by xanthine oxidoreductase activity. Free Radic Res 35(6):665–679

    PubMed  Article  CAS  Google Scholar 

  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Activation of nuclear factor-kB is a key event in brain tolerance. J Neurosci 21:4668–4677

    PubMed  CAS  Google Scholar 

  • Bondy SC, Le Bel CP (1993) The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Radic Biol Med 14(6):633–642

    PubMed  Article  CAS  Google Scholar 

  • Caccamo D, Campisi A, Currò M, Li Volti G, Vanella A, Ientile R (2004) Excitotoxic and post-ischemic neurodegeneration: involvement of transglutaminases. Amino Acids 27:373–379

    PubMed  Article  CAS  Google Scholar 

  • Caccamo D, Campisi A, Currò M, Bramanti V, Tringali M, Li Volti G, Vanella A, Ientile R (2005a) Antioxidant treatment inhibited glutamate-evoked NF-kappaB activation in primary astroglial cell cultures. Neurotoxicology 26:915–921

    PubMed  Article  CAS  Google Scholar 

  • Caccamo D, Campisi A, Marini H, Adamo EB, Li Volti G, Squadrito F, Ientile R (2005b) Glutamate promotes NF-kappaB pathway in primary astrocytes: protective effects of IRFI 016, a synthetic vitamin E analogue. Exp Neurol 193:377–383

    PubMed  Article  CAS  Google Scholar 

  • Caccamo D, Campisi A, Currò M, Aguennouz M, Li Volti G, Avola R, Ientile R (2005c) Nuclear factor-kappab activation is associated with glutamate-evoked tissue transglutaminase up-regulation in primary astrocyte cultures. J Neurosci Res 82:858–865

    PubMed  Article  CAS  Google Scholar 

  • Caccamo D, Currò M, Condello S, Ferlazzo N, Ientile R, Caccamo D (2010) Critical role of transglutaminase and other stress proteins during neurodegenerative processes. Amino Acids 38(2):653–658

    PubMed  Article  CAS  Google Scholar 

  • Calkins MJ, Townsend JA, Johnson DA, Johnson JA (2010) Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Exp Neurol 224(1):307–317

    PubMed  Article  CAS  Google Scholar 

  • Campisi A, Caccamo D, Li Volti G, Currò M, Parisi G, Avola R, Vanella A, Ientile R (2004) Glutamate-evoked redox state alterations are involved in tissue transglutaminase up-regulation in primary astrocyte cultures. FEBS Lett 578:80–84

    PubMed  Article  CAS  Google Scholar 

  • Currò M, Condello S, Caccamo D, Ferlazzo N, Parisi G, Ientile R (2009) Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells. Amino Acids 36(4):725–730

    PubMed  Article  Google Scholar 

  • Ferlazzo N, Condello S, Currò M, Parisi G, Ientile R, Caccamo D (2008) NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells. BMC Neurosci 9:62–68

    PubMed  Article  Google Scholar 

  • Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534–539

    PubMed  Article  CAS  Google Scholar 

  • Fésüs L, Szondy Z (2005) Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579(15):3297–3302

    PubMed  Article  Google Scholar 

  • Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM (2004) Cystamine increases l-cysteine levels in Huntington’s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem 91(2):413–422

    PubMed  Article  CAS  Google Scholar 

  • Fujita K, Shibayama K, Yamauchi M, Kato T, Ando M, Takahashi H, Iritani K, Yoshimoto N, Nagata Y (1998) Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development. Neurochem Res 23(4):557–562

    PubMed  Article  CAS  Google Scholar 

  • Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396

    PubMed  Article  CAS  Google Scholar 

  • Groenen PJ, Seccia M, Smulders RH, Gravela E, Cheeseman KH, Bloemendal H, de Jong WW (1993) Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites. Biochem J 295(Pt 2):399–404

    PubMed  CAS  Google Scholar 

  • Gross SR, Balklava Z, Griffin M (2003) Importance of tissue transglutaminase in repair of extracellular matrices and cell death of dermal fibroblasts after exposure to a solarium ultraviolet A source. J Invest Dermatol 121:412–423

    PubMed  Article  CAS  Google Scholar 

  • Gundemir S, Johnson GV (2009) Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS One 4(7):e6123

    PubMed  Article  Google Scholar 

  • Ientile R, Caccamo D, Griffin M (2007) Tissue transglutaminase and the stress response. Amino Acids 33:385–394

    PubMed  Article  CAS  Google Scholar 

  • Iismaa SE, Mearns BM, Lorand L, Graham RM (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89:991–1023

    PubMed  Article  CAS  Google Scholar 

  • Jeong EM, Kim CW, Cho SY, Jang GY, Shin DM, Jeon JH, Kim IG (2009) Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress. FEBS Lett 583(4):648–654

    PubMed  Article  CAS  Google Scholar 

  • Jou MJ (2008) Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen-species generation in astrocytes. Adv Drug Deliv Rev 60(13–14):1512–1526

    PubMed  Article  CAS  Google Scholar 

  • Lee ZW, Kwon SM, Kim SW, Yi SJ, Kim YM, Ha KS (2003) Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. Biochem Biophys Res Commun 305:633–640

    PubMed  Article  CAS  Google Scholar 

  • Lesort M, Tucholski J, Zhang J, Johnson GV (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J Neurochem 75:1951–1961

    PubMed  Article  CAS  Google Scholar 

  • Luciani A, Villella VR, Vasaturo A, Giardino I, Raia V, Pettoello-Mantovani M, D’Apolito M, Guido S, Leal T, Quaratino S, Maiuri L (2009) SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol 183(4):2775–2784

    PubMed  Article  CAS  Google Scholar 

  • Luciani A, Villella VR, Vasaturo A, Giardino I, Pettoello-Mantovani M, Guido S, Cexus ON, Peake N, Londei M, Quaratino S, Maiuri L (2010a) Lysosomal accumulation of gliadin p31–43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma down-regulation in intestinal epithelial cells and coeliac mucosa. Gut 59(3):311–319

    PubMed  Article  Google Scholar 

  • Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, D’Apolito M, Guido S, Masliah E, Spencer B, Quaratino S, Raia V, Ballabio A, Maiuri L (2010b) Detective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12(9):863–875

    PubMed  Article  CAS  Google Scholar 

  • Milakovic T, Tucholski J, McCoy E, Johnson GV (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279:8715–8722

    PubMed  Article  CAS  Google Scholar 

  • Monti D, Salvioli S, Capri M, Malorni W, Straface E, Cossarizza A, Botti B, Piacentini M, Baggio G, Barbi C, Valensin S, Bonafè M, Franceschi C (2000) Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech Ageing Dev 121(1–3):239–250

    PubMed  CAS  Google Scholar 

  • Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A (2005) Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide. Anticancer Res 25(3B):1945–1951

    PubMed  CAS  Google Scholar 

  • Ortigosa SM, Díaz-Vivancos P, Clemente-Moreno MJ, Pintó-Marijuan M, Fleck I, Veramendi J, Santos M, Hernandez JA, Torné JM (2010) Oxidative stress induced in tobacco leaves by chloroplast over-expression of maize plastidial transglutaminase. Planta 232(3):593–605

    PubMed  Article  CAS  Google Scholar 

  • Park D, Choi SS, Ha KS (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39:619–631

    PubMed  Article  CAS  Google Scholar 

  • Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasco L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W (2002) Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 81:1061–1072

    PubMed  Article  CAS  Google Scholar 

  • Ruan Q, Johnson GV (2007) Transglutaminase 2 in neurodegenerative disorders. Front Biosci 12:891–904

    PubMed  Article  CAS  Google Scholar 

  • Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG (2004) Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 279:15032–15039

    PubMed  Article  CAS  Google Scholar 

  • Shin DM, Jeon JH, Kim CW, Cho SY, Lee HJ, Jang GY, Jeong EM, Lee DS, Kang JH, Melino G, Park SC, Kim IG (2008) TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 22(7):2498–2507

    PubMed  Article  CAS  Google Scholar 

  • Smethurst PA, Griffin M (1996) Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J 313:803–808

    PubMed  CAS  Google Scholar 

  • Song H, Kim BK, Chang W, Lim S, Song BW, Cha MJ, Jang Y, Hwang KC (2011) Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress. J Recept Signal Transduct Res 31(1):66–74

    PubMed  Article  CAS  Google Scholar 

  • Takano K, Shiraiwa K, Moriyama M, Nakamura Y (2010) Transglutaminase 2 expression induced by lipopolysaccharide stimulation together with NO synthase induction in cultured astrocytes. Neurochem Int 57(7):812–818

    PubMed  Article  CAS  Google Scholar 

  • Telci D, Griffin M (2006) Tissue transglutaminase (TG2)-a wound response enzyme. Front Biosci 11:867–882

    PubMed  Article  CAS  Google Scholar 

  • Tucholski J, Johnson GVW (2002) Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem 81:780–791

    PubMed  Article  CAS  Google Scholar 

  • Tucholski J, Lesort M, Johnson GV (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102(2):481–491

    PubMed  Article  CAS  Google Scholar 

  • Verderio E, Nicholas B, Gross S, Griffin M (1998) Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 239:119–138

    PubMed  Article  CAS  Google Scholar 

  • Villalobos E, Santos M, Talavera D, Rodríguez-Falcón M, Torné JM (2004) Molecular cloning and characterization of a maize transglutaminase complementary DNA. Gene 336(1):93–104

    PubMed  Article  CAS  Google Scholar 

  • Wang JY, Wen LL, Huang YN, Chen YT, Ku MC (2006) Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12(27):3521–3533

    PubMed  Article  CAS  Google Scholar 

  • Yi SJ, Choi HJ, Yoo JO, Yuk JS, Jung HI, Lee SH, Han JA, Kim YM, Ha KS (2004) Arachidonic acid activates tissue transglutaminase and stress fiber formation via intracellular reactive oxygen species. Biochem Biophys Res Commun 325:819–826

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Riccardo Ientile.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Caccamo, D., Currò, M., Ferlazzo, N. et al. Monitoring of transglutaminase2 under different oxidative stress conditions. Amino Acids 42, 1037–1043 (2012). https://doi.org/10.1007/s00726-011-1018-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-011-1018-8

Keywords

  • Transglutaminase 2
  • Oxidative stress
  • Neurodegeneration
  • Autoimmune diseases